Exploring Plasma Proteome Thermal Stability in Peripheral Arterial Disease: Biophysical Findings Under Cilostazol Therapy
<b>Introduction</b>: Intermittent claudication, an early symptom of peripheral artery disease, can be treated by cilostazol to alleviate symptoms and improve walking distance. Our previous investigation focused on cilostazol-induced alterations in the thermodynamic properties of plasma,...
Saved in:
| Main Authors: | Dorottya Szabó, László Benkő, Dénes Lőrinczy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/6/886 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Benefits of Cilostazol’s Effect on Vascular and Neuropathic Complications Caused by Diabetes
by: Diego Castro Musial, et al.
Published: (2024-12-01) -
Effect of Cilostazol on Myocardial Histomorphological Changes in Ischemia-Reperfusion Injury
by: Anar Amrah, et al.
Published: (2025-03-01) -
Blood Flow Restricted Training as the Last-Opportunity, Non-Invasive Treatment for a Patient Suffering from Peripheral Arterial Disease Without Possibility for Implementing Conventional Walking Exercise Rehabilitation – a Case Report
by: Mikołaj Maga, et al.
Published: (2023-05-01) -
Patients with peripheral artery disease demonstrate altered expression of soluble and membrane-bound immune checkpoints
by: Rosanne D. Reitsema, et al.
Published: (2025-07-01) -
Effects of cilostazol for in-stent restenosis after carotid artery stenting: a meta-analysis
by: Jing Sun, et al.
Published: (2025-06-01)